Inflation, currency headwinds take toll on CSL’s profit

Record levels of plasma collections has helped CSL beat guidance with an adjusted full-year profit of $US2.61 billion ($A4 billion), up 20 per cent from last year when adjusted for currency fluctuations. CSL’s statutory full-year net profit after tax was down three per cent to $US2.19 billion ($A3.38 billion), as a stronger US dollar diminished earnings […]